MXCT vs WAB · rev $38.6M vs P/E 38, rev $10.39B
MaxCyte Inc (MXCT) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported WAB revenue for 2024-12-31 was $10.39B. Net income was $1.07B. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
MXCT currently screens at market cap $124.3M. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the MXCT and WAB stock pages for the full models.
Not investment advice.